Table 3.
Prevalence Proportion Ratio (PR) of Screening by Age Group, Region, and Charlson Comorbidity Index (CCI). N= 650,003
| Unadjusted PR (95% CI) | Model 1 PR (95% CI) | Model 2 PR (95% CI) | |
|---|---|---|---|
| Age | |||
| 50–54 years | 1 (ref) | - | 1 (ref) |
| 55–59 years | 1.01 (1.01–1.01) | - | 1.01 (1.01–1.01) |
| 60–64 years | 1.00 (0.99–1.00) | - | 1.01 (1.00–1.01) |
| 65–69 years | 0.94 (0.94–0.95) | - | 0.95 (0.95–0.96) |
| Region | |||
| Capital | 1 (ref) | 1 (ref) | 1 (ref) |
| Central Denmark | 1.06 (1.06–1.06) | 1.06 (1.05–1.06) | 1.06 (1.05–1.06) |
| North Denmark | 1.06 (1.05–1.06) | 1.06 (1.05–1.06) | 1.06 (1.05–1.06) |
| Zealand | 1.11 (1.11–1.12) | 1.11 (1.11–1.12) | 1.11 (1.11–1.12) |
| Southern Denmark | 1.17 (1.17–1.18) | 1.17 (1.17–1.18) | 1.17 (1.17–1.18) |
| CCI | |||
| 0 | 1 (ref) | 1 (ref) | 1 (ref) |
| 1–2 | 0.95 (0.95–0.96) | 0.96 (0.95–0.96) | 0.96 (0.95–0.96) |
| ≥3 | 0.79 (0.78–0.80) | 0.80 (0.79–0.81) | 0.80 (0.79–0.81) |
Notes: Model 1: Region and CCI adjusted for age group. Model 2: Mutually adjusted.